Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization.
about
LRP-1: a checkpoint for the extracellular matrix proteolysisFunctional interactions between Sp1 or Sp3 and the helicase-like transcription factor mediate basal expression from the human plasminogen activator inhibitor-1 genePlasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosisThe plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategiesMouse aortic ring assay: A new approach of the molecular genetics of angiogenesisRelative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer.Plasminogen Activator Inhibitor-1 in Cancer: Rationale and Insight for Future Therapeutic TestingDifferential gene expression by endothelial cells in distinct angiogenic statesbcn-1 Element-dependent activation of the laminin gamma 1 chain gene by the cooperative action of transcription factor E3 (TFE3) and Smad proteinsHuman bladder cancer invasion model using rat bladder in vitro and its use to test mechanisms and therapeutic inhibitors of invasionDecrease of breast cancer cell invasiveness by sodium phenylacetate (NaPa) is associated with an increased expression of adhesive moleculesOverexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patientsTransient reduction of placental angiogenesis in PAI-1-deficient miceSynergistic Gene Expression Signature Observed in TK6 Cells upon Co-Exposure to UVC-Irradiation and Protein Kinase C-Activating Tumor PromotersExpression pattern of the urokinase-plasminogen activator system in rat DS-sarcoma: role of oxygenation status and tumour sizeCaveolin-1 knockout mice show an impaired angiogenic response to exogenous stimuliPAI-1-dependent endothelial cell death determines severity of radiation-induced intestinal injuryuPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy.Plasminogen activator inhibitor 1 functions as a urokinase response modifier at the level of cell signaling and thereby promotes MCF-7 cell growth.Soluble urokinase-type plasminogen activator receptor inhibits cancer cell growth and invasion by direct urokinase-independent effects on cell signaling.Paradoxical pro-invasive effect of the serine proteinase inhibitor tissue factor pathway inhibitor-2 on human hepatocellular carcinoma cells.Pooling and Analysis of Published in Vitro Data: A Proof of Concept Study for the Grouping of Nanoparticles.Epitope mapping for four monoclonal antibodies against human plasminogen activator inhibitor type-1: implications for antibody-mediated PAI-1-neutralization and vitronectin-binding.Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate.Interleukin 12 induces activation of fibrinolysis and coagulation in humans.Selective loss of TGFbeta Smad-dependent signalling prevents cell cycle arrest and promotes invasion in oesophageal adenocarcinoma cell linesTumoral and choroidal vascularization: differential cellular mechanisms involving plasminogen activator inhibitor type I.uPA is upregulated by high dose celecoxib in women at increased risk of developing breast cancer.Polymorphic variation of genes in the fibrinolytic system and the risk of ovarian cancer.Does plasminogen activator inhibitor-1 drive lymphangiogenesis?Genetic events and the role of TGF beta in epithelial tumour progression.Tissue inhibitors of matrix metalloproteinases in cancer.PAI-1 Regulates the Invasive Phenotype in Human Cutaneous Squamous Cell Carcinoma.Modeling metastasis in the mouse.SFRP1 reduction results in an increased sensitivity to TGF-β signaling.Placenta growth factor (PlGF), a novel inducer of plasminogen activator inhibitor-1 (PAI-1) in sickle cell disease (SCD).Integrative network analysis reveals active microRNAs and their functions in gastric cancer.PRCC, the commonest TFE3 fusion partner in papillary renal carcinoma is associated with pre-mRNA splicing factors.Plasminogen activator inhibitor-1 and the kidney.Pleiotropic functions of plasminogen activator inhibitor-1.
P2860
Q21285122-0D545EFF-9BF6-412F-9564-4029F696FA74Q22010204-683D2097-F2E8-45AF-9727-4330444CD1DDQ24319106-6E0E4643-4FE7-4388-BB86-E77A1F7FD627Q24671642-8A0B262B-15D8-4E49-BB92-983375DB4B29Q24797401-A484FF20-C8BC-47D5-A353-3BCAD1B5F686Q24797550-500993A3-F69C-4BC6-BBFC-E062BB898B04Q26801060-E6EF98CC-EC43-4A9B-AFEE-4C5859C54E85Q28143112-28D343BF-3078-4EFC-BEED-F979780C0DE6Q28216002-8D7A5EA5-82B8-4C5B-AA47-4BA396CEFB40Q28350937-6A441E3E-A504-4447-9EE8-8B526AA3A2CCQ28360887-EEBE985B-9DD1-45F0-A5A5-78B73EE206B9Q28366039-1873AB52-6332-40B4-8AF1-2FCC038B7F53Q28510418-295D4D68-081B-4ABC-90E8-5A4D3773FB70Q28550021-F313D72F-9A8D-4843-9981-AA42F57899B4Q28565213-809FF9CB-D612-4CB3-96E5-B48AEDD364C8Q28587327-3175C5D1-5989-4F03-B5BD-8EF4F6E7F499Q28730314-1218093E-B1DB-4461-9F5C-5AC0C404774DQ30249137-DA03A7DD-438B-47B2-AF84-97EFA782493EQ30307084-CDE3E31C-702F-4824-A601-8185AD6F5BADQ30311208-B3ECC1CA-2739-48B9-8A30-2CAE2010362BQ30909624-EAEF0107-A16E-4369-8334-FF2B91A02CFAQ31018385-9867965E-162B-4F91-8F0F-CF284426C526Q31944726-A11498D3-EE91-4C5A-8EFF-E8776E0B4F10Q32159522-C8EBB577-39EA-4697-8903-FD9344B34C02Q33181606-E5BE7B31-6DD6-4A40-AE3E-C057AC60A755Q33271014-99B82A51-B631-49F4-9EAB-A773F51EF056Q33295022-FD05635F-E0AB-4434-A680-BD2733D7667EQ33376876-9CC65EFB-16E7-4D1D-96C4-FCD9DDA4BCF9Q33467391-F4B80C47-9663-4E39-BCA0-B3742849D996Q33543002-D58E33AE-E94D-44E7-ADBC-F38D6035EF0AQ33643339-A7EA2DC2-806A-4F3C-A1CF-A357189B26D9Q33692913-78684CEF-C5B3-43BF-9F7F-B47BA880E7ABQ33693105-0135DF9B-E0E4-4A74-A128-DE307EA3DEFDQ33739285-91485A29-38BA-490B-AE57-F5BE6EA80B19Q33814892-C8E956FB-0E14-4DF2-A07A-4B77A88BB2A0Q33883207-3D2CEFC6-FFB1-47BA-A2F5-F75534C9FAB2Q33942494-4D66E68D-3623-451C-AA47-E9082563C723Q33943447-C37E8F1A-1AB0-4605-9A76-21FE01AD6A1EQ33960082-04880A18-87A1-4A85-8188-1D3D89A9EFDAQ33984228-70438171-16AD-4583-82C6-80757CE67F64
P2860
Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Absence of host plasminogen ac ...... invasion and vascularization.
@en
Absence of host plasminogen ac ...... invasion and vascularization.
@nl
type
label
Absence of host plasminogen ac ...... invasion and vascularization.
@en
Absence of host plasminogen ac ...... invasion and vascularization.
@nl
prefLabel
Absence of host plasminogen ac ...... invasion and vascularization.
@en
Absence of host plasminogen ac ...... invasion and vascularization.
@nl
P2093
P356
P1433
P1476
Absence of host plasminogen ac ...... r invasion and vascularization
@en
P2093
C Holst-Hansen
J M Foidart
N E Fusenig
P Carmeliet
R D Gerard
P2888
P304
P356
10.1038/NM0898-923
P407
P577
1998-08-01T00:00:00Z